165 related articles for article (PubMed ID: 25193978)
1. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.
Ferrari MJ; Fermon F; Nackers F; Llosa A; Magone C; Grais RF
Int Health; 2014 Dec; 6(4):282-90. PubMed ID: 25193978
[TBL] [Abstract][Full Text] [Related]
2. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
3. Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.
Nnadi C; Oladejo J; Yennan S; Ogunleye A; Agbai C; Bakare L; Abdulaziz M; Mohammed A; Stephens M; Sumaili K; Ronveaux O; Maguire H; Karch D; Dalhat M; Antonio M; Bita A; Okudo I; Nguku P; Novak R; Bolu O; Shuaib F; Ihekweazu C
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1352-1356. PubMed ID: 29240724
[TBL] [Abstract][Full Text] [Related]
4. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
5. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14.
Funk A; Uadiale K; Kamau C; Caugant DA; Ango U; Greig J
PLoS Curr; 2014 Dec; 6():. PubMed ID: 25685621
[TBL] [Abstract][Full Text] [Related]
6. Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
Ajibola O; Omoleke SA; Omisakin OA
Vaccine; 2018 Mar; 36(11):1423-1428. PubMed ID: 29426659
[TBL] [Abstract][Full Text] [Related]
7. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
[TBL] [Abstract][Full Text] [Related]
8. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.
Carod Artal FJ
Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF
BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
[TBL] [Abstract][Full Text] [Related]
12. Priority during a meningitis epidemic: vaccination or treatment?
Veeken H; Ritmeijer K; Hausman B
Bull World Health Organ; 1998; 76(2):135-41. PubMed ID: 9648353
[TBL] [Abstract][Full Text] [Related]
13. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C
PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549
[TBL] [Abstract][Full Text] [Related]
14. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.
Cooper LV; Ronveaux O; Fernandez K; Lingani C; Goumbi K; Ihekweazu C; Preziosi MP; Durupt A; Trotter CL
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S244-S252. PubMed ID: 31671446
[TBL] [Abstract][Full Text] [Related]
16. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
17. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.
Arifin SMN; Zimmer C; Trotter C; Colombini A; Sidikou F; LaForce FM; Cohen T; Yaesoubi R
Med Decis Making; 2019 Jul; 39(5):553-567. PubMed ID: 31268405
[No Abstract] [Full Text] [Related]
19. Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger.
Maïnassara HB; Oumarou GI; Issaka B; Sidiki A; Idi I; Pelat JM; Fontanet A; Mueller JE
Trop Med Int Health; 2017 Feb; 22(2):196-204. PubMed ID: 27860062
[TBL] [Abstract][Full Text] [Related]
20. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
